Introduction:

Cardiovascular Devices Market was valued at US$ 66.1 Billion in 2024 and is projected to grow at a CAGR of 7.90% to reach US$ 132.3 Billion by 2034.

The cardiovascular devices market describes the worldwide market for medical equipment intended especially for the detection, cure, and management of cardiovascular disorders (CVDs). For a number of cardiovascular disorders, such as peripheral vascular illnesses, heart failure, arrhythmias, and coronary artery disease, these devices are essential to the delivery of efficient healthcare solutions. Cardiovascular illnesses are a major cause of morbidity and death worldwide. Multiple factors, including the rising global frequency of cardiovascular disorders, are driving the market for cardiovascular devices. The burden of cardiovascular diseases is rising due to a number of causes, including an aging population, sedentary lifestyles, poor eating habits, and an increase in the frequency of risk factors including obesity, diabetes, and hypertension.

The growing elderly population and increased risk of cardiovascular disease are expected to fuel cardiovascular market expansion throughout the projected period. According to the World Health Organization (WHO), in 2020, there were more elderly Americans in the United States—60 years of age and older—than there will be children under the age of five. Additionally, the number of elderly individuals 60 years of age and older will quadruple to reach 21 billion by 2050, while the number of elderly individuals 80 years of age and older is projected to increase three times between 2020 and 2050 to reach 426 million.

In addition to these, factors like the expansion of awareness campaigns regarding the administration of cardiovascular devices, rising investments, and the availability of more over-the-counter medications are believed to be propelling the growth of the global cardiovascular devices market during the forecasted duration. Although, the high cost of cardiovascular devices and stringent policies put up by the authorities have significantly hindered the growth of cardiovascular devices market.

The market for cardiovascular medical devices is expected to grow in the next years due to an increase in the prevalence of cardiac conditions such cardiac arrhythmias, coronary heart disease, and heart attacks.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Cardiovascular Devices Market Key Drivers:

• Rising prevalence of Cardiovascular disorders

The rising incidence of chronic cardiovascular illnesses worldwide is a major factor driving the global market for cardiovascular devices. In the United States, cardiovascular disease is the greatest cause of mortality for both men and women as well as for individuals from the majority of racial and ethnic groups, according to Center for Disease Control and Prevention, Cardiovascular disease claims one life in the United States every 33 seconds. Cardiovascular disease claimed the lives of about 695,000 Americans in 2021, accounting for 1 in 5 fatalities.

Increasing salt intake, increasing tobacco use, an increase in the incidence of smoking, and increased alcohol use are the main causes of cardiovascular illnesses. If cardiovascular disorders are identified early on, they can be efficiently treated. Thus, it is anticipated that the growing need for early identification of cardiovascular disorders will propel the worldwide market for cardiovascular devices. Additionally, the risks of cardiovascular disorders are rising due to an alarming growth in the number of obese people and geriatric population, with physical inactivity, which is predicted to increase the demand for cardiovascular devices globally, and hence propelling the cardiovascular devices market.

• Technological Advancements

Over the past ten years, significant advancements have been made in the technology used to produce cardiovascular devices and the applications for these devices. As a result, more patients are receiving therapy using cardiovascular devices, which has produced excellent treatment and monitoring outcomes. Improved diagnostic and treatment cardiovascular devices are frequently needed by patients with advanced cardiovascular disease stages. This is a result of increased demand and increased awareness for medical devices with improved safety characteristics, such as coronary stents. The needs of the patient include devices that don't result in negative side effects like infections, which can be brought on by a variety of stent types, including bare-metal stents.

Artificial intelligence in cardiovascular devices is one such advancement that greatly helps cardiology since it is more adept at tracking certain cardiac issues. For instance, in July 2021, the US FDA approved Medtronic's use of two AccuRhythm AI algorithms, enhancing the accuracy of the information clinicians get to help them recognize and manage irregular cardiac rhythms.

Cardiovascular Devices Market Restrains:

• Barriers to research, development and high cost

Limitations to the research and development among the new research activities to continuously enhance the quality of Cardiovascular devices are several. Various market key players dream of launching new and improved products continuously, but the ineffectivity in the processes and high cost of the cardiovascular devices pose a high risk to the large companies in the cardiovascular devices market. As a result, small ventures of institutions cannot afford these costly, high-end equipment and hence this factor hinders the growth potential of cardiovascular devices market.

• Rigid regulatory policies

The cardiovascular devices need to be precise and accurate in delivering proper diagnosis of the patient, proper compatibility in the patient’s body, and easy for patient to use. The company’s manufacturing the Cardiovascular devices, need to comply with the set regulatory guidelines for the product which in turn could pose in loss of a massive investment by the manufacturers.

Cardiovascular Devices Market is segmented based on Product, Application, End User and region.

Product Insights:

• Cardiovascular Monitoring and Diagnostic Devices:

Cardiovascular Monitoring and Diagnostic Devices such as the ECGs, blood pressure monitors, imaging equipment like echocardiograms are included in this segment. These devices are crucial for early detection and diagnosis of CVDs.

• Coronary Stents:

Coronary stents are used to expand narrow arteries, used to diagnose for coronary artery disease. These stents are surgically placed in the patient’s body easy flow of blood through the coronary artery 

• Pacemakers:

Pacemakers are used to regulate the rhythm of the heart in conditions like arrhythmia. It helps to pump the blood efficiently and in a rhythmic manner.

• Defibrillators:

Defibrillators are electric devices that are used to regulate the heart rhythm using shock waves through electric current. It helps in cases like heart failure to start the normal functioning of the heart.

• Interventional Cardiac Devices:

Interventional cardiac devices like catheters are used for minimally invasive procedures like angioplasty and valve repair. These devices are used in surgical procedures for cardiac surgeries.

• Heart Valves:

Heart valves are artificially inserted into the heart to mechanically perform the valves’ function. The damaged valves of the heart are replaced with mechanical and bioprosthetic options. This issue usually widely affects the elderly population. 

• Cardiac Ablation Catheters:

The cardiac ablation catheters are used for the safe removal of the unwanted tissue causing the abnormal rhythm of the heart.

• Ventricular Assist Devices:

Ventricular assist devices are instruments to support the failing heart until it is transplanted or fully recovered. These are an absolute support system for the patients who are critically ill.

Among all the segments mentioned above, the segment that dominates the most is the cardiovascular monitoring and diagnostic devices because of its importance for early diagnosis of the disease and wide application across various cardiovascular diseases and routine checkup.

Application Insights:

• Coronary Heart Disease:

Coronary heart disease is the leading cause of cardiovascular disorder deaths. The damaged coronary artery is fixed using devices like stents, bypass surgery equipment and imaging devices.

• Sudden Cardiac Arrest:

During a sudden cardiac arrest, the patient has a sure chance to lose their pulse. For this to be avoided implantable defibrillators play a crucial role. This life saving nature of this device helps patients to increase their life expectancy.

• Stroke:

A stroke is a neurological disability brought on by a disruption in blood flow to the brain. Stroke therapy and prevention are aided by monitoring and interventional cardiac devices.

• Rheumatic Heart Disease:

Heart-related streptococcal infections that go untreated can cause rheumatic heart disease (RHD). Heart valve replacement or repair is an essential part of treating RHD.

• Cerebrovascular Heart Disease:

Blood vessel disorders that supply the brain are a part of cerebrovascular heart disease. In order to treat cerebrovascular disorders, stents and catheters are utilized during interventional treatments.

Among all of the segments mentioned above the segment that dominates the most is the Coronary heart disease segment due its high prevalence in adults with unhealthy lifestyle, different technological advancements, and greater awareness among the population.

End User Insights:

• Hospitals:

The primary end-users that provide thorough cardiovascular care are hospitals. Their substantial market share is attributed to their handling of intricate situations, surgical procedures, and long-term care. Hospitals have specialized departments that handle cardiovascular diagnoses and therapies.

• Ambulatory Surgery Centers:

Ambulatory Surgical Centers (ASCs) specialize on minimally invasive therapies as well as outpatient procedures. ASCs provide cardiovascular treatment to patients with ease, lower expenses, and faster recovery times.

• Diagnostic Clinics:

Cardiovascular diseases are the focus of diagnostic clinics, which also offer preventative treatment and early diagnosis. In diagnostic testing, patient education, and routine check-ups, they are indispensable. In addition to increasing accessibility, diagnostic clinics help decentralize cardiovascular treatment.

Among the three segments of the end-user category, the segment that dominates the most is the Hospitals segment, due to their growing patient pool, and high concentration of qualified and professional personnel.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Cardiovascular Devices Market Regional Insights:

• North America market is estimated to witness the largest revenue share over the forecast period, due to its large target patient pool, increasing consumer awareness of commercially accessible items, and high adoption of state-of-the-art surgical techniques. Furthermore, the government's sanctions for hospitals that fail to prevent patient readmissions are driving a significant increase in the use of home healthcare equipment, which in turn is driving up demand for cardiovascular monitoring and diagnostic systems.
• Asia Pacific market is estimated to witness fastest revenue share due to increasing prevalence of cardiovascular diseases, growing adoption of advanced technologies, rising government policies and awareness to a healthy lifestyle.
• Europe market is the second largest market owing to the drastic rise in the prevalence of heart diseases affected because of higher consumption of alcohol, unhealthy diet, lack of exercise, smoking, etc.
• Latin America market is growing as the prevalence of a cardiovascular disorders is on the rise, also the government is taking initiatives to raise awareness regarding cardiovascular devices.
• Middle East & Africa market is estimated to show slow or moderate growth due to delayed adoption of emerging technologies, but the region is growing rapidly and is anticipated to show rise in the cardiovascular devices market.

Report Scope:

Attribute	Details
Market Size 2024	US$ 66.1 billion
Projected Market Size 2034	US$ 132.3 billion
CAGR Growth Rate	7.9%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product - Cardiovascular Monitoring and Diagnostic Devices, Coronary Stents, Pacemakers, Defibrillators, Interventional Cardiac Devices, Heart Valves, Cardiac Ablation Catheters, and Ventricular Assist Devices. By Application - Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Rheumatic Heart Disease, and Cerebrovascular Heart Disease. By End User - Hospitals, Ambulatory Surgery Centers, and Diagnostic Clinics.
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Cardiovascular Devices Market report based on Product, Application, End User and region:

Cardiovascular Devices Market, By Product:

• Cardiovascular Monitoring and Diagnostic Devices
• Coronary Stents
• Pacemakers
• Defibrillators
• Interventional Cardiac Devices
• Heart Valves
• Cardiac Ablation Catheters
• Ventricular Assist Devices

Cardiovascular Devices Market, By Application:

• Coronary Heart Disease
• Sudden Cardiac Arrest
• Stroke
• Rheumatic Heart Disease
• Cerebrovascular Heart Disease

Cardiovascular Devices Market, By End User:

• Hospitals
• Ambulatory Surgery Centers
• Diagnostic Clinics

Cardiovascular Devices Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Cardiovascular Devices Market includes, Medtronic plc, LivaNova plc, Getinge Group, Terumo Corporation, Becton Dickinson and Company, Stryker Corporation, Abbott Laboratories, General Electric Company, Boston Scientific Corporation, and Edwards Lifesciences Corporation.

Recent Development:

• In February 2022, The acquisition of Baylis Medical Company Inc., which provided sophisticated transseptal access solutions as well as guidewires, sheaths, and dilators to facilitate catheter-based left-heart surgeries, was announced by Boston Scientific Corporation.
• In July 2021, The US launch of Abbott's newest implantable cardiac monitor (ICM), the Jot Dx, was announced. In order to assist patients, establish and maintain a connection with their ICM, Jot DX ICM is backed by SyncuP, a customized service that provides one-on-one training and instruction.
• In February 2020, AliveCor, a well-known provider of business cardiac solutions and Al-based electrocardiogram (EC) technology, launched an application called the KardiaMobile, which is used to record, store, and transfer a single channel of electrocardiogram patterns in the Mexican region from the Federal Commission to protect against hygiene risks. This launch is made possible by a partnership between AliveCor and Inpharamo, a medical solutions supplier with headquarters located in Mexico.

• Medtronic plc*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• LivaNova plc
• Getinge Group
• Terumo Corporation
• Becton Dickinson and Company
• Stryker Corporation
• Abbott Laboratories
• General Electric Company
• Boston Scientific Corporation
• Edwards Lifesciences Corporation

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Product
     • Market Snippet, By Application
     • Market Snippet, By End User
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysish
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation, By Product, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Cardiovascular Monitoring
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Diagnostic Devices
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Coronary Stents
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Pacemakers
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Defibrillators
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Interventional Cardiac Devices
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Heart Valves
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cardiac Ablation Catheters
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Ventricular Assist Devices
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Coronary Heart Disease
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Sudden Cardiac Arrest
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Stroke
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Rheumatic Heart Disease
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cerebrovascular Heart Disease
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End Users, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospitals
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Diagnostic Clinics
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Ambulatory Surgical Centres
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years

• Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • U.S.
  • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

Competitive Landscape

• Heat Map Analysis
• Market Presence and Specificity Analysis

Company Profiles 

• Medtronic Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• LivaNova plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Getinge Group
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Terumo Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Becton Dickinson and Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Stryker Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact